logo

OGEN

OragenicsยทAMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

OGEN Profile

Oragenics, Inc.

A company that develops antibiotics, oral health products and weight loss products

Pharmaceutical
--
04/10/2013
American Stock Exchange
3
12-31
Common stock
1990 Main Street, Suite 750, Sarasota, Florida 34236
--
Oragenics, Inc. (formerly Oragen Co., Ltd.) was established in November 1996, but its business activities did not start until 1999. The company is a developing company dedicated to the research and development of nasal drug delivery in the field of neurology and the fight against infectious diseases. The company's leading product, ONP-002, is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and can cross the blood-brain barrier, rapidly reducing swelling, oxidative stress and inflammation, while restoring proper blood flow through gene amplification.